首页|滋阴化痰方治疗阴虚痰凝型良性甲状腺结节的临床疗效

滋阴化痰方治疗阴虚痰凝型良性甲状腺结节的临床疗效

扫码查看
[目的]探讨滋阴化痰方(由消瘰丸加味组方而成)治疗阴虚痰凝型良性甲状腺结节的临床疗效.[方法]将62例阴虚痰凝型良性甲状腺结节患者随机分为试验组和对照组,每组各31例.2组患者均给予清淡饮食、少食辛辣刺激食物、适当运动和保持心情舒畅等基础治疗,在此基础上,试验组给予滋阴化痰方治疗,对照组给予左甲状腺素钠片治疗,疗程为3个月.观察2组患者治疗前后中医证候积分、甲状腺结节最大直径及甲状腺功能指标的变化情况,并评价2组患者的临床疾病疗效和中医证候疗效.[结果](1)疾病疗效方面,治疗3个月后,试验组的总有效率为90.32%(28/31),对照组为48.39%(15/31),组间比较,试验组的临床疾病疗效明显优于对照组(P<0.05).(2)中医证候疗效方面,治疗3个月后,试验组的总有效率为77.42%(24/31),对照组为38.71%(12/31),组间比较,试验组的中医证候疗效明显优于对照组(P<0.01).(3)中医证候积分方面,治疗后,试验组的中医证候积分较治疗前明显降低(P<0.01),而对照组无明显降低(P>0.05);组间比较,试验组对中医证候积分的降低作用明显优于对照组(P<0.05).(4)结节最大直径方面,治疗后,2组患者的甲状腺结节最大直径均较治疗前缩小(P<0.05或P<0.01),且试验组对甲状腺结节最大直径的缩小作用优于对照组(P<0.05).(5)甲状腺功能指标方面,2组患者在治疗前后的各项甲状腺功能指标均无明显变化,差异均无统计学意义(P>0.05).[结论]滋阴化痰方在改善良性甲状腺结节患者临床症状、缩小甲状腺结节方面疗效显著,且无明显不良反应,具有较高的安全性.
Clinical Efficacy of Ziyin Huatan Prescription in the Treatment of Benign Thyroid Nodules with Yin Deficiency and Phlegm Coagulation Type
Objective To investigate the clinical efficacy of Ziyin Huatan Prescription(derived from flavored Xiaoluo Pills,mainly with the functions of nourishing yin and resolving phlegm)in the treatment of benign thyroid nodules(TN)of yin deficiency and phlegm coagulation type.Methods Sixty-two benign TN patients with yin deficiency and phlegm coagulation type were randomly divided into the trial group and the control group,with 31 patients in each group.Both groups were required to stick to a light diet with less spicy and stimulating food,appropriate exercise and ease of mind.Moreover,the trial group was given oral use of Ziyin Huatan Prescription,and the control group was given oral use of Levothyroxine Sodium Tablets for a period of 3 months.The changes of traditional Chinese medicine(TCM)syndrome scores,maximum diameter of thyroid nodules and thyroid function indexes in the two groups were observed before and after the treatment.After treatment,the clinical disease efficacy and TCM syndrome efficacy were evaluated in the two groups.Results(1)After 3 months of treatment,the total effective rate for disease efficacy in the trial group was 90.32%(28/31),and that in the control group was 48.39%(15/31).The intergroup comparison showed that the clinical disease efficacy of the trial group was significantly superior to that of the control group(P<0.05).(2)After 3 months of treatment,the total effective rate for TCM syndrome efficacy in the trial group was 77.42%(24/31),and that in the control group was 38.71%(12/31).The intergroup comparison showed that the TCM syndrome efficacy of the trial group was significantly superior to that of the control group(P<0.01).(3)After treatment,the TCM syndrome scores of the trial group were significantly decreased compared with those before treatment(P<0.01),while no obvious changes were shown in the control group(P>0.05).The intergroup comparison showed that the reduction of TCM syndrome scores in the trial group was significantly superior to that in the control group(P<0.05).(4)After treatment,the maximum diameter of TN in both groups was reduced compared with that before treatment(P<0.05 or P<0.01),and the reduction of the maximum diameter of TN in the trial group was superior to that in the control group(P<0.05).(5)There were no significant changes in the thyroid function indexes of the two groups before and after treatment,and the differences were not statistically significant(P>0.05).Conclusion Ziyin Huatan Prescription is effective on improving clinical symptoms and reducing the size of TN in patients with benign TN,without obvious adverse effects and with high safety.

Ziyin Huatan PrescriptionXiaoluo Pillsbenign thyroid nodules(TN)yin deficiency and phlegm coagulationTCM syndromeclinical efficacy

林才云、王炜

展开 >

广州中医药大学第五临床医学院,广东广州 510405

广东省第二中医院,广东广州 510095

滋阴化痰方 消瘰丸 良性甲状腺结节 阴虚痰凝 中医证候 临床疗效

2024

广州中医药大学学报
广州中医药大学

广州中医药大学学报

CSTPCD
影响因子:1.055
ISSN:1007-3213
年,卷(期):2024.41(1)
  • 16